Novartis division Sandoz to set up Global Capability Centre in Hyderabad

The Sandoz team also included Chief Scientific Officer Claire D'Abreau-Hayling, Sandoz Development Centre India head Dr. Vandana Singh, and Novartis Corporate Centre head Naveen Gullapalli.

The Minister also noted that Hyderabad boasts a top-notch business environment backed by the state, with a strong emphasis on the life sciences industry. "Hyderabad is already home to Novartis and has grown into the second largest location for the company, we are looking forward to a similar patronage and association with Sandoz," he said.

Sandoz is a global leader in generic pharmaceuticals and biosimilars. As a division of the Novartis Group, their vision is to discover new ways to improve and extend people's lives. The global portfolio of Sandoz comprises approximately 1,000 molecules, covering all major therapeutic areas, which accounted for 2019 sales of $9.7 billion. Their products reach more than 500 million patients globally.

Hyderabad is regarded as the life sciences capital of India and vaccine capital of the world. It also has the unique distinction of being home to the largest development centres outside of their headquarters for all of the most valued technology companies including Amazon, Google, Apple, Microsoft, Facebook (Meta), etc.

Read also: Sandoz signs agreement to acquire antifungal agent Mycamine from Astellas